377,45 €
419,39 €
-10% with code: EXTRA
Progress in Molecular Biology and Translational Science
Progress in Molecular Biology and Translational Science
377,45
419,39 €
  • We will send in 10–14 business days.
Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications,…
  • Publisher:
  • ISBN-10: 0128177403
  • ISBN-13: 9780128177402
  • Format: 15.2 x 22.9 x 3 cm, hardcover
  • Language: English
  • SAVE -10% with code: EXTRA

Progress in Molecular Biology and Translational Science (e-book) (used book) | bookbook.eu

Reviews

Description

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases--30 Years Clinical Applications in China, and more.

EXTRA 10 % discount with code: EXTRA

377,45
419,39 €
We will send in 10–14 business days.

The promotion ends in 18d.20:12:53

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 4,19 Book Euros!?
  • Publisher:
  • ISBN-10: 0128177403
  • ISBN-13: 9780128177402
  • Format: 15.2 x 22.9 x 3 cm, hardcover
  • Language: English English

Glycans and Glycosaminoglycans as Clinical Biomarkers and Therapeutics - Part B, Volume 163 in the Progress in Molecular Biology and Translational Science series, provides informative monographs on a variety of research topics related to Glycans and glycosaminoglycans as clinical biomarkers and therapeutics. Topics in this update include an Overview of Fugal Glycan-based Therapeutics, Heparin: An Essential Drug for Modern Medicine, Low Molecular Weight Heparins and Their Clinical Applications, The Clinical Use of Fondaparinux: A Synthetic Heparin Pentasaccharid, Heparinoids as Clinically Used Drugs, Marine Glycan-Derived Therapeutics in China, Efficacy of Heparinoid PSS in Treating Cardiovascular and other Diseases--30 Years Clinical Applications in China, and more.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)